Pharmaceutical Accountability Foundation

Home Tags Good Covid-19 Company Practices Scorecard

Tag: Good Covid-19 Company Practices Scorecard

The Pharmaceutical Accountability Foundation invites you to join our event presenting the Fair Pharma Scorecard, on Thursday 30 June 4PM CET.  Please register here. Fair Pharma Scorecard To what extent do pharmaceutical companies comply with human rights during the Covid-19 pandemic? Do they serve the global public interest and the right to...
Wemos and the Pharmaceutical Accountability Foundation are proud and pleased to receive a donation of 500,000 euros from the Dutch National Postcode Lottery. With this support, we commit to improving access to affordable corona vaccines and medicines for everyone. We strive for a world in which everyone's health takes...
On Thursday 3 March the Pharmaceutical Accountability Foundation hosted the Making Pharma Fair Webinar, with panelists Hans Hogerzeil, Ella Weggen and Jaume Vidal. Occassion for organizing the webinar are our recently published Guidelines for Responsible Pharmaceutical Behaviour, which Rosalind Turkie presented. Missed the webinar or want to listed back a...
Webinar on Thursday 3 March 3 PM CET Register here How have pharmaceutical companies been performing according to international human rights principles in the pandemic? The Pharmaceutical Accountability Foundation has been monitoring this in our GCCP scorecard, which ranks pharmaceutical companies according to HR principles and international standards. The aim of...
We feel inspired by yesterday's engaging event. Panelists shared their stories about using legal strategies for promoting access to medicines, ranging from HIV treatment action campaigns, using human rights to promote access to medicines in Brazil, compulsory licensing in Russia, TRIPS flexibilities, and the possibility of holding pharma accountable...
On Thursday, 30 september, we hosted our event 'Discussing pharmaceutical human rights accountability during Covid-19'. We look back on a fruitful and engaging international expert panel discussion. The event counted a number of international and diverse attendees, joining from countries such as Chile, Norway, Germany, France, the UK, Switzerland and...
An International Expert Panel Discussion on Good Covid-19 Company Practices (GCCP) The Pharmaceutical Accountability Foundation is organising an event on its Good Covid-19 Company Practices (GCCP) project on september 30th 2021, 15:00-16:30 CET. The event will be an introduction to the GCCP and what we have learned so far on how...
Research by SOMO and Wemos has shown that the EU has transferred an amount of more than 10 billion dollars to the Swiss bank account of vaccine manufacturer Moderna. In addition, the Moderna vaccine patents are also housed in another tax haven: Delaware in the United States, where royalties...
Bergeijk, 22 January 2021 – Pharmaceutical Accountability Foundation  (PAF) publishes a GCCP scorecard of pharmaceutical companies that develop important vaccines and pharmaceuticals for the Corona pandemic. “Despite their almost unanimous endorsement of human rights principles that ensure fair, global access to vaccines and pharmaceuticals, in reality, companies’ behaviour does not...